Case Study: CellPort Software for Gene Therapy Potency Assay Release Testing

This case study describes the use of the CellPort Cell Culture Suite Software-as-a-Service (SaaS) platform in the Process Analytical Development (PAD) stage for development and transition into a fully compliant GMP potency assay release test for a commercially approved gene therapy product and the positive impact that the platform had on improving the secure and compliant transfer of the technology and protocols to a GMP setting.